The Oncology Institute Inc (NAS:TOI)
$ 0.4337 0.026 (6.27%) Market Cap: 32.28 Mil Enterprise Value: 86.29 Mil PE Ratio: 0 PB Ratio: 0.78 GF Score: 28/100

Q4 2023 Oncology Institute Inc Earnings Call Transcript

Mar 27, 2024 / 09:00PM GMT
Release Date Price: $1.84 (+8.88%)
Operator

Good afternoon, and welcome to The Oncology Institute's fourth quarter 2023 and full year 2023 earnings conference call. Today's call is being recorded, and we have allocated one hour of prepared remarks and Q&A.

At this time, I'd like to turn the conference over to Mark Hueppelsheuser, General Counsel at TOI. Thank you. You may begin.

Mark Hueppelsheuser
The Oncology Institute, Inc. - General Counsel

The press release announcing The Oncology Institute's results for the fourth quarter and full year 2023 are available at the investors section of the company's website, theoncologyinstitute.com. A replay of this call will also be available at the company's website after the conclusion of this call.

Before we get started, I would like to remind you of the company's Safe Harbor language included in the company's press release for the fourth quarter and full year 2023. Management may make forward-looking statements, including guidance and underlying assumptions.

Forward looking statements are based on expectations that involve risks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot